tiprankstipranks
Advertisement
Advertisement

DE:ECQ0 Stock Latest News

Neurizon Therapeutics Discloses Director Departure and Remaining Equity Interests
Company AnnouncementsNeurizon Therapeutics Discloses Director Departure and Remaining Equity Interests
2h ago
Neurizon Therapeutics appoints Dr Ross Murdoch as new director
PremiumCompany Announcements
Neurizon Therapeutics appoints Dr Ross Murdoch as new director
2h ago
Neurizon Targets Investor Visibility with NUZ-001 ALS Update at Microcap Conference
PremiumCompany Announcements
Neurizon Targets Investor Visibility with NUZ-001 ALS Update at Microcap Conference
1d ago
Neurizon steps up investor outreach with NUZ-001 ALS briefing series
PremiumCompany Announcements
Neurizon steps up investor outreach with NUZ-001 ALS briefing series
12d ago
Neurizon Therapeutics Seeks Quotation of 4.18 Million New Shares on ASX
PremiumCompany Announcements
Neurizon Therapeutics Seeks Quotation of 4.18 Million New Shares on ASX
12d ago
Neurizon Advances NUZ-001 in HEALEY ALS Trial and Fortifies Balance Sheet
PremiumCompany AnnouncementsNeurizon Advances NUZ-001 in HEALEY ALS Trial and Fortifies Balance Sheet
12d ago
Neurizon Clears 33.2m New Shares After Entitlement Offer Shortfall Placement
Premium
Company Announcements
Neurizon Clears 33.2m New Shares After Entitlement Offer Shortfall Placement
21d ago
Neurizon Therapeutics Seeks ASX Quotation for 33.2 Million New Shares
Premium
Company Announcements
Neurizon Therapeutics Seeks ASX Quotation for 33.2 Million New Shares
21d ago
Neurizon launches national investor briefings as ALS program enters key phase
PremiumCompany Announcements
Neurizon launches national investor briefings as ALS program enters key phase
26d ago
Neurizon Raises A$2.7m via Entitlement Offer Shortfall to Advance ALS Drug NUZ-001
PremiumCompany Announcements
Neurizon Raises A$2.7m via Entitlement Offer Shortfall to Advance ALS Drug NUZ-001
26d ago
Neurizon issues shares for investor relations as it advances ALS-focused pipeline
PremiumCompany Announcements
Neurizon issues shares for investor relations as it advances ALS-focused pipeline
1M ago
Neurizon Therapeutics Seeks ASX Quotation for 750,000 New Shares
PremiumCompany Announcements
Neurizon Therapeutics Seeks ASX Quotation for 750,000 New Shares
1M ago
Neurizon preclinical data show NUZ-001 boosts dual protein-clearance pathways in ALS models
PremiumCompany AnnouncementsNeurizon preclinical data show NUZ-001 boosts dual protein-clearance pathways in ALS models
1M ago
Neurizon Director Increases Stake Through $150,000 Share Placement
Premium
Company Announcements
Neurizon Director Increases Stake Through $150,000 Share Placement
2M ago
Neurizon Sets April 2026 Expiry for NUZOA Listed Options
Premium
Company Announcements
Neurizon Sets April 2026 Expiry for NUZOA Listed Options
2M ago
Neurizon to Present NUZ-001 Science in HEALEY ALS Platform Trial Webinar
PremiumCompany Announcements
Neurizon to Present NUZ-001 Science in HEALEY ALS Platform Trial Webinar
2M ago
Neurizon Issues Director Shares, Affirms Compliance and Transparency
PremiumCompany Announcements
Neurizon Issues Director Shares, Affirms Compliance and Transparency
2M ago
Neurizon Therapeutics Seeks ASX Quotation for 9.5 Million New Shares
PremiumCompany Announcements
Neurizon Therapeutics Seeks ASX Quotation for 9.5 Million New Shares
2M ago
Neurizon CEO Michael Thurn Resigns as Biotech Launches Global Search for Successor
PremiumCompany Announcements
Neurizon CEO Michael Thurn Resigns as Biotech Launches Global Search for Successor
2M ago
Neurizon Expands NUZ-001 Huntington’s Disease Data at ASENT 2026
PremiumCompany AnnouncementsNeurizon Expands NUZ-001 Huntington’s Disease Data at ASENT 2026
2M ago
Neurizon Therapeutics Options Lapse, Trimming Potential Equity Overhang
Premium
Company Announcements
Neurizon Therapeutics Options Lapse, Trimming Potential Equity Overhang
2M ago
Neurizon Draws First $5m Tranche to Advance ALS Drug Trial
Premium
Company Announcements
Neurizon Draws First $5m Tranche to Advance ALS Drug Trial
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >